Classify a variation
Describe the change and see which variation type it is, with the regulation and the classification guideline cited.
See the prompt
Is adding a 40 mg strength to our tablet a Type IB variation?
CMC change management for EU variations. Workbench reads your change proposal against the Variations Regulation and the classification guidelines and cites each condition. Fee Calculation prices the variation in every market, and Alerts flags a rule change that touches a planned filing.
Non-sterile oral tablet
Same process and in-process controls
GMP certificate for oral tablets
Fee Calculation then prices the variation for the reference member state and each concerned member state.
Type IA, IB or II decides what you file, when you may implement the change and what it costs in each market. The answer sits in a long classification list where every entry has its own conditions. A change filed one category too low comes back at validation. One filed too high waits for an approval it did not need.
Built on the source
Tightening the limit is a Type IA variation in the EU. [2]
Notify within 12 months of implementing it. [1]
In the US it goes in the annual report. [5]
The approved limit is Q = 75% at 45 min. [D1]
Workbench reads the change proposal and the approved dossier sections against each classification condition. It cites the regulation and the guideline, and marks what it could not confirm from your documents.
Type IA, IB and II variations carry different fees at each agency. Fee Calculation gives the fee per market for the procedure, with the source of every fee line.
Alerts matched the revised EU variations framework, which applies from 15 January 2026, to four Ostra products whose annual Type IA updates were planned under the old grouping.
Ostra wants Site B added for Atorvastatin 20 mg tablets, authorised through a DCP with Czechia as reference member state. Workbench reads the change proposal and the approved manufacturing section before Sara books the submission.
Each of these is a quick task in Workbench or a tool with a screen of its own. Picking a quick task writes the prompt for you; add your product and market, and the answer comes back with its sources.
Describe the change and see which variation type it is, with the regulation and the classification guideline cited.
Is adding a 40 mg strength to our tablet a Type IB variation?
Set the procedure, markets and product details and get each authority's fee, with its source and payment instructions.
Open Fee CalculationExplore reporting routes for a tighter dissolution specification.
Compare how tightening a dissolution acceptance criterion for an approved immediate-release tablet is assessed under EU variations and US NDA/ANDA post-approval change requirements. Explain possible reporting categories, their conditions, and supporting data. Cite current official guidance and identify what must be known before choosing a route.
Identify study conditions, time points, and product-specific inputs.
Outline a stability programme for a new immediate-release oral tablet intended for the EU and US. Cover batch selection, storage conditions, test attributes, time points, and packaging considerations using current applicable ICH and agency guidance. State assumptions and the data needed to justify a shelf life.
Map the proposed transfer to filing options and evidence needs.
Using the attached change proposal and approved CMC sections, assess the EU variation route for adding a manufacturing site for an oral tablet. Identify applicable classification conditions, supporting data, related changes, and implementation constraints. Cite current variations guidance and flag information needed to confirm the route.
Check consistency across the change summary and supporting data.
Review the attached CMC change summary and supporting studies for the stated market. Identify inconsistencies, unsupported claims, missing validation or stability evidence, and likely authority questions. Provide a prioritised gap table with document references; do not infer results that are not supplied.
Each classification condition is shown with its status and the passage it comes from: the regulation, the guideline or your own document.
Where a condition cannot be confirmed from what you attached, Workbench says so and names the document it needs.
Fee Calculation prices Type IA, IB and II variations per market, so the budget is known before the submission date is booked.
What the legislation and the agencies' guidance say, in plain language, with the sources linked.
See Workbench, Fee Calculation and Alerts on your own products and markets in a 30-minute walkthrough.